BHA butylated hydroxyanisole
Selected indexed studies
- A review of the occurrence, metabolites and health risks of butylated hydroxyanisole (BHA). (J Sci Food Agric, 2023) [PMID:37127924]
- Butylated hydroxyanisole (BHA). (Rep Carcinog, 2004) [PMID:21089817]
- Butylated hydroxyanisole (BHA). (IARC Monogr Eval Carcinog Risk Chem Hum, 1986) [PMID:3473000]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A review of the occurrence, metabolites and health risks of butylated hydroxyanisole (BHA). (2023) pubmed
- Butylated hydroxyanisole (BHA). (2004) pubmed
- Butylated hydroxyanisole (BHA). (1986) pubmed
- Butylated hydroxyanisole (BHA). (2002) pubmed
- Cytotoxicity and apoptosis induction by butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). (2003) pubmed
- Butylated hydroxyanisole in perspective. (1991) pubmed
- Butylated hydroxyanisole isomers induce distinct adipogenesis in 3T3-L1 cells. (2019) pubmed
- Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat. (1999) pubmed
- Effect of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on rat erythrocytes. (1986) pubmed
- Butylated hydroxyanisole induces vascular endothelial injury via TFEB-mediated degradation of GPX4 and FTH1. (2024) pubmed